ALZHEIMER

Summary

ALZHEIMER is a gene associated with Alzheimer’s disease pathology and neurodegenerative processes. It plays a significant role in disease activation, neuroinflammation modulation, and cellular senescence pathways. The gene has been identified as a therapeutic target in multiple neurodegenerative disease contexts and serves as a biomarker for Alzheimer’s disease.

---

Biological Function

ALZHEIMER participates in multiple biological pathways relevant to neurodegeneration:

• Inflammation Regulation: Inhibits both general Inflammation and Neuroinflammation (strength: 1.00)
• Senescence Association: Associated with cellular Senescence processes (strength: 1.00)
• Aging Modulation: Exhibits inhibitory effects on Aging (strength: 1.00)
• Pathway Activation: Activates the Complement pathway (strength: 1.00)
• Neurodegeneration Activation: Activates both NEURODEGENERATIVE DISEASES and NEURODEGENERATIVE DISORDERS genes (strength: 1.00)

---

Key Relationships

Outgoing Relationships (ALZHEIMER → others)

Relationship	Target	Strength
activates	Alzheimer (disease)	1.00
biomarker_for	Alzheimer (disease)	1.00
interacts_with	Alzheimer (disease)	1.00
activates	NEURODEGENERATIVE DISEASES (gene)	1.00
activates	NEURODEGENERATIVE DISORDERS (gene)	1.00
activates	Complement (pathway)	1.00
inhibits	Neuroinflammation (disease)	1.00
inhibits	Inflammation (disease)	1.00
inhibits	Aging (disease)	1.00
associated_with	Senescence (disease)	1.00

Incoming Relationships (others → ALZHEIMER)

Relationship	Source Gene	Strength
therapeutic_target	DEMENTIA	1.00
therapeutic_target	TAU	1.00
therapeutic_target	NEURODEGENERATION	1.00
activates	APP/PS1	1.00
activates	TAU	1.00
activates	TREM2	1.00
activates	OXIDATIVE STRESS	1.00
biomarker_for	NEURODEGENERATION	1.00
protects_against	NEURODEGENERATION	1.00
inhibits	APOPTOSIS	1.00

---

Research Context

Hypotheses Involving ALZHEIMER

1. Closed-loop transcranial focused ultrasound with 40Hz gamma entrainment to restore hippocampal-cortical connectivity in early MCI (Score: 1.00)

• Explores PVALB modulation to restore neural connectivity in early mild cognitive impairment

2. Metabolic Reprogramming to Reverse Senescence (Score: 1.00)

• Investigates metabolic mechanisms to reverse cellular senescence in neurodegeneration

3. TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration (Score: 0.99)

• Examines TREM2-mediated immune cell interactions in neurodegenerative contexts

4. TREM2-Dependent Microglial Senescence Transition (Score: 0.95)

• Studies microglial senescence pathways controlled by TREM2

5. Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons (Score: 0.95)

• Targets specific interneuron populations to restore hippocampal gamma oscillations in Alzheimer’s disease

SciDEX Analyses

No SciDEX analyses have been documented for this entity.

---

Disease Associations

Primary Disease: Alzheimer’s Disease

• ALZHEIMER activates Alzheimer’s disease pathology
• Serves as a biomarker for disease detection
• Interacts_with the disease through multiple pathways

Related Disease Processes

• Neuroinflammation: Inhibited by ALZHEIMER, suggesting anti-inflammatory regulatory function
• Senescence: Associated with cellular aging processes
• Aging: Inhibited by ALZHEIMER activity
• Complement Pathway: Activated by ALZHEIMER, indicating involvement in immune-mediated mechanisms

---

References

1. PMID 34553778: “Ferroptosis as a mechanism of neurodegeneration in Alzheimer’s disease.”

2. PMID 32781522: “Involvement of p38 MAPK in Synaptic Function and Dysfunction.”

3. PMID 39307583: “Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine.”

4. PMID 36843263: “Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease.”

5. PMID 28163132: “Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases.”